Res Pract Thromb Haemost
July 2025
Background: Recent studies have demonstrated decreased rates of venous thrombotic events, including pulmonary embolism (PE), in patients taking statins. It, however, remains elusive whether statins could also impact PE severity.
Objectives: To investigate a potential association between statin use and the severity of PE in a retrospective cohort.
Patients with primary brain tumors have a high risk of venous thromboembolism (VTE). This study aims to estimate the prevalence of asymptomatic VTE and to identify risk factors and biomarkers for asymptomatic VTE in patients with brain tumors by screening for asymptomatic LE-DVT. Fifty patients were included in the study.
View Article and Find Full Text PDFEvaluating the predictive role of endothelial dysfunction in the development of vasculopathy-mediated complications in patients with limited cutaneous systemic sclerosis (lcSSc). 38 patients with lcSSc who were naïve for vasculopathy-mediated complications, defined as absent pre-existing digital ulcers (DU), pulmonary hypertension (PH) and symptomatic atherosclerotic cardiovascular diseases, were prospectively observed during a 3-years follow-up period. At study enrolment, functional and laboratory parameters of endothelial dysfunction were assessed.
View Article and Find Full Text PDFCritical limb threatening ischemia (CLTI) is associated with a one-year mortality rate of up to 25% making prompt diagnosis essentially. This study aims to investigate if cardiac biomarkers may serve as an effective tool for risk stratification in patients with lower extremity artery disease (LEAD). For this cross-sectional retrospective analysis, 21712 patients with LEAD were screened for eligibility from 2004 to 2020.
View Article and Find Full Text PDFMult Scler J Exp Transl Clin
April 2025
Background: Multiple sclerosis (MS) involves symptoms that may be impacted by angiogenesis. Vascular endothelial growth factor (VEGF), a potent pro-angiogenic molecule, is elevated in early MS, but its activity in later disease is understudied. [Met]-enkephalin (ENK) has anti-angiogenic activity and is decreased in persons with MS (PwMS).
View Article and Find Full Text PDFThe new guidelines for the management of peripheral arterial and aortic diseases (PAAD) from the European Society of Cardiology and endorsed by the European Society of Vascular Medicine (ESVM), emphasize on a comprehensive and multidisciplinary approach focusing on prevention, diagnosis, treatment, and follow-up of patients with a wide range of PAAD, including lower extremity peripheral arterial disease (PAD). The aim of this summary, focusing on PAD and coordinated by the Young Academy of ESVM, is to provide young angiologists with the fundamental principles of these guidelines and to assist them in navigating their everyday clinical practice. PAD diagnosis relies on objective evaluation of flow/oxygen reduction at rest, with arterial ultrasound as the first imaging modality to confirm the presence of arterial lesions.
View Article and Find Full Text PDFBackground: The Vienna Prediction Model (VPM) identifies patients with a first unprovoked deep vein thrombosis of the leg and/or pulmonary embolism who have a low recurrence risk and may, therefore, not benefit from extended-phase anticoagulation.
Objectives: The aim of this study was to evaluate patients with a predicted high risk of recurrent venous thromboembolism (VTE).
Methods And Results: We prospectively followed 266 patients in whom the VPM had predicted a recurrence risk of more than 5.
J Craniomaxillofac Surg
October 2023
Proc Natl Acad Sci U S A
August 2023
Int Immunopharmacol
December 2022
Int J Mol Sci
March 2022
Front Cardiovasc Med
February 2022